Best U.S. fund managers of '18 buying healthcare, pot stocks as market wobbles [Reuters (UK)]
Biogen Inc. (BIIB)
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
biogen.com/en_us/investors.html
Company Research
Source: Reuters
Best U.S. fund managers of '18 buying healthcare, pot stocks as market wobbles | Reuters 5 Min Read NEW YORK (Reuters) - The top-performing U.S. growth fund managers of the last year are taking the recent slide in the U.S. stock market to add to their bets in companies they expect will continue to expand regardless of the direction of the overall economy. Among their top bets: life science companies like Biogen Inc ( BIIB.O ), laboratory supply company Thermo Fisher Scientific Inc ( TMO.N ), and Canadian cannabis company Tilray Inc ( TLRY.O ). The bullishness comes at a time when U.S. stock investors must weigh a strong domestic economy against the threats to growth posed by rising interest rates and a global economic slowdown exacerbated by higher trade tariffs between the United States and China, the world’s largest economies. The S&P 500 tumbled in the fourth quarter, edging close to the 20 percent decline from its high that would signify a bear market. Since hitting a low on
Show less
Read more
Impact Snapshot
Event Time:
BIIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
News
- Should You Be Confident in Biogen (BIIB)? [Yahoo! Finance]Yahoo! Finance
- What's in Store for Biogen (BIIB) This Earnings Season? [Yahoo! Finance]Yahoo! Finance
- Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $290.00 to $270.00. They now have an "outperform" rating on the stock.MarketBeat
- Alzheimer's Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
BIIB
Earnings
- 2/14/24 - Miss
BIIB
Sec Filings
- 4/12/24 - Form PRE
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- BIIB's page on the SEC website